Fig. 3
From: Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40425-019-0756-0/MediaObjects/40425_2019_756_Fig3_HTML.png)
CPI microscopic colitis clinical course. Summary of immunotherapy treatment history, symptom onset and duration, and initiation of budesonide for the 13 patients in the microscopic colitis cohort. Patient 12 received systemic guideline-dose glucocorticoids, represented in green below